European Healthtech startup funding raised during Q3 2016.
In Q3 2016, 86 European Healthtech companies raised a combined €473M across 90 funding rounds, down 40.8% versus Q3 2015. Ireland led by capital raised, and Amadeus Capital Partners was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Carrick Therapeutics | Series A | Sep 2016 | €86M |
| IOmx Therapeutics | Series A | Aug 2016 | €40M |
| Genomics Medicine Ireland | Series A | Sep 2016 | €36M |
| Genfit | Growth/Late |
6 exits · €24M disclosed.
| Luck Genome | Acquisition | Sep 2016 | €11M |
| Cellink | IPO | Jul 2016 | €8.1M |
| Linkcare | Acquisition | Sep 2016 | €5.0M |
| Sep 2016 |
| €34M |
| BONESUPPORT | Growth/Late | Sep 2016 | €33M |
| Spineart | Growth/Late | Aug 2016 | €30M |
| Artios | Series A | Aug 2016 | €29M |
| Vivasure Medical | Series C | Aug 2016 | €16M |
| Inflazome | Series A | Aug 2016 | €15M |
| Physidia | Growth/Late | Sep 2016 | €15M |
| Rigontec | Series A | Aug 2016 | €14M |
| Fortimedix | Series A | Sep 2016 | €11M |
| Eyevensys | Series A | Aug 2016 | €9.0M |
| H4D | Series B | Aug 2016 | €6.7M |
| Fluidic Analytics | Series B | Sep 2016 | €6.2M |
